We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Sides With FDA in Compounding Lawsuit
The U.S. District Court for the District of Columbia has ruled in FDA’s favor in a compounding case, deciding that the agency was right in barring a company from producing and selling a compounded version of vasopressin.